...
首页> 外文期刊>Korean Circulation Journal >Diagnostic Value of Tc-99m MIBI Myocardial Perfusion Scintigraphy during Maximal Coronary Artery Dilation Adenosine in Coronary Artery Disease
【24h】

Diagnostic Value of Tc-99m MIBI Myocardial Perfusion Scintigraphy during Maximal Coronary Artery Dilation Adenosine in Coronary Artery Disease

机译:Tc-99m MIBI心肌灌注显像对最大冠状动脉扩张腺苷在冠状动脉疾病中的诊断价值

获取原文
           

摘要

Background & Method Pharmacological coronary vasodilation induced by dipyridamole is often used in association with thallium-201 scintigraphy to evaluate the presence and prognostic significance of coronary artery disease(CAD). Although dipyridamole has traditionally been used for this purpose, it causes frequent side effect, which at times can be life-threatening. Moreover, dipyridamole dose not elicit maximal coronary vasodilation in a substantial number of patients receiving the usual i.v. dose. Adenosine is an endogenously produced compound that has significant effects as a coronary vasodilator and rapid onset action and extremely short half-life( Results Adenosine induced a significant decrease in systolic(p Conclusion Thus, these facts suggest that pharmacological coronary vasodilation with adenosine in conjuction with Tc-99m MIBI myocardial scintigraphy appears to be a feasible, safe and valuable test for the diagnosis of coronary artery disease, particulary in patients unable to exercise.
机译:背景与方法由双嘧达莫诱导的药理性冠状动脉血管扩张术常与th 201闪烁显像技术结合使用,以评估冠状动脉疾病(CAD)的存在及其对预后的意义。尽管传统上使用潘生丁用于此目的,但它会引起频繁的副作用,有时可能会危及生命。此外,双嘧达莫在接受常规静脉内注射的大量患者中并未引起最大的冠脉扩张。剂量。腺苷是一种内源性产生的化合物,具有作为冠状动脉血管舒张剂的显着作用,起效快,半衰期极短(结果腺苷可引起收缩期显着降低(p结论),因此,这些事实表明,腺苷与冠状动脉舒张剂合用具有药理作用。 Tc-99m MIBI心肌闪烁显像似乎是诊断冠心病的可行,安全且有价值的检查方法,特别是对于无法运动的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号